CHSYF
Price
$0.93
Change
-$0.00 (-0.00%)
Updated
May 1 closing price
Capitalization
4.12B
CNADF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Apr 10 closing price
Capitalization
30.01M
Interact to see
Advertisement

CHSYF vs CNADF

Header iconCHSYF vs CNADF Comparison
Open Charts CHSYF vs CNADFBanner chart's image
China Medical System Holdings
Price$0.93
Change-$0.00 (-0.00%)
Volume$110
Capitalization4.12B
CANADABIS CAP
Price$0.06
Change-$0.00 (-0.00%)
Volume$6K
Capitalization30.01M
CHSYF vs CNADF Comparison Chart in %
Loading...
CNADF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHSYF vs. CNADF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHSYF is a Hold and CNADF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CHSYF: $0.93 vs. CNADF: $0.06)
Brand notoriety: CHSYF and CNADF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CHSYF: 100% vs. CNADF: 100%
Market capitalization -- CHSYF: $4.12B vs. CNADF: $30.01M
CHSYF [@Pharmaceuticals: Other] is valued at $4.12B. CNADF’s [@Pharmaceuticals: Other] market capitalization is $30.01M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHSYF’s FA Score shows that 1 FA rating(s) are green whileCNADF’s FA Score has 1 green FA rating(s).

  • CHSYF’s FA Score: 1 green, 4 red.
  • CNADF’s FA Score: 1 green, 4 red.
According to our system of comparison, CNADF is a better buy in the long-term than CHSYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNADF’s TA Score shows that 2 TA indicator(s) are bullish.

  • CNADF’s TA Score: 2 bullish, 0 bearish.

Price Growth

CHSYF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while CNADF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHSYF($4.12B) has a higher market cap than CNADF($30M). CNADF YTD gains are higher at: 78.571 vs. CHSYF (0.000). CHSYF has higher annual earnings (EBITDA): 3.74B vs. CNADF (4.73M). CHSYF has more cash in the bank: 5.25B vs. CNADF (2.79M). CNADF has less debt than CHSYF: CNADF (6.97M) vs CHSYF (1.8B). CHSYF has higher revenues than CNADF: CHSYF (8.94B) vs CNADF (21.6M).
CHSYFCNADFCHSYF / CNADF
Capitalization4.12B30M13,733%
EBITDA3.74B4.73M78,947%
Gain YTD0.00078.571-
P/E Ratio8.13N/A-
Revenue8.94B21.6M41,398%
Total Cash5.25B2.79M188,514%
Total Debt1.8B6.97M25,872%
FUNDAMENTALS RATINGS
CHSYF: Fundamental Ratings
CHSYF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
40
PRICE GROWTH RATING
1..100
72
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CHSYFCNADF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
8%
Bullish Trend 4 days ago
34%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
7%
Bullish Trend 4 days ago
45%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CNADF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SIMS36.920.61
+1.67%
SPDR® S&P Kensho Intelligent Strctr ETF
PALC49.580.46
+0.94%
Pacer Lunt Large Cap Mlt Ftr Alt ETF
NFJ12.600.03
+0.24%
Virtus Dividend Interest & Premium Strategy Fund
GEND10.71N/A
N/A
Genter Capital Dividend Income ETF
SRTY15.50-0.43
-2.70%
ProShares UltraPro Short Russell2000

CHSYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHSYF has been loosely correlated with CNADF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CHSYF jumps, then CNADF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHSYF
1D Price
Change %
CHSYF100%
N/A
CNADF - CHSYF
38%
Loosely correlated
N/A
SBFM - CHSYF
30%
Poorly correlated
-6.06%
SXTC - CHSYF
23%
Poorly correlated
+5.62%
TKNO - CHSYF
22%
Poorly correlated
+2.36%
CANN - CHSYF
7%
Poorly correlated
+4.34%
More

CNADF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNADF has been loosely correlated with CHSYF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CNADF jumps, then CHSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
CHSYF - CNADF
38%
Loosely correlated
N/A
ZTS - CNADF
24%
Poorly correlated
+0.06%
CPHI - CNADF
20%
Poorly correlated
+5.44%
CLSH - CNADF
6%
Poorly correlated
+0.14%
ESAIY - CNADF
5%
Poorly correlated
+0.28%
More